TWI848832B - 用曲妥珠單抗安坦辛治療殘存乳癌之方法 - Google Patents

用曲妥珠單抗安坦辛治療殘存乳癌之方法 Download PDF

Info

Publication number
TWI848832B
TWI848832B TW112138682A TW112138682A TWI848832B TW I848832 B TWI848832 B TW I848832B TW 112138682 A TW112138682 A TW 112138682A TW 112138682 A TW112138682 A TW 112138682A TW I848832 B TWI848832 B TW I848832B
Authority
TW
Taiwan
Prior art keywords
methods
breast cancer
trastuzumab emtansine
treating residual
residual breast
Prior art date
Application number
TW112138682A
Other languages
English (en)
Other versions
TW202402328A (zh
Inventor
梅蘭妮 史密特
Original Assignee
美商建南德克公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 美商建南德克公司 filed Critical 美商建南德克公司
Publication of TW202402328A publication Critical patent/TW202402328A/zh
Application granted granted Critical
Publication of TWI848832B publication Critical patent/TWI848832B/zh

Links

TW112138682A 2018-10-15 2019-04-24 用曲妥珠單抗安坦辛治療殘存乳癌之方法 TWI848832B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862745914P 2018-10-15 2018-10-15
US62/745,914 2018-10-15

Publications (2)

Publication Number Publication Date
TW202402328A TW202402328A (zh) 2024-01-16
TWI848832B true TWI848832B (zh) 2024-07-11

Family

ID=

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017087280A1 (en) 2015-11-16 2017-05-26 Genentech, Inc. Methods of treating her2-positive cancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017087280A1 (en) 2015-11-16 2017-05-26 Genentech, Inc. Methods of treating her2-positive cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
期刊 IAN E KROP ET AL Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trial Lancet Oncol 18,6 20170516 1-12

Similar Documents

Publication Publication Date Title
EP3565844B8 (en) Methods of treating cancer with anti-pd-1 antibodies
EP3630089A4 (en) PROCEDURE FOR CANCER THERAPY
EP3883580A4 (en) METHODS OF TREATMENT OF CANCER
EP3606531A4 (en) CANCER TREATMENT METHODS
EP3610026A4 (en) BLADDER CANCER TREATMENT METHODS
IL286297A (en) Minimal residual cancer treatment methods
EP3787625A4 (en) METHODS OF TREATMENT OF CANCER
IL284850A (en) Methods of treating breast cancer with toctinib
EP3886867A4 (en) METHODS OF TREATMENT OF WHSC1 OVEREXPRESSING CANCER BY INHIBITION OF SETD2
IL277981A (en) Cancer treatment methods
IL279591A (en) Cancer treatment methods using combination therapy
SG11202107017TA (en) Methods of treating cancer
IL289811A (en) A method for treating cancer
EP3723765A4 (en) CANCER TREATMENT METHODS
IL281600A (en) Methods of treating cancer
IL283742A (en) An innovative approach to cancer treatment through immune modulation
EP4061846A4 (en) METHODS OF TREATING CANCER USING ANTI-OX40 ANTIBODIES IN COMBINATION WITH ANTI-TIGIT ANTIBODIES
IL290213A (en) Methods for treating multifocal cancer
EP4072561A4 (en) CANCER TREATMENT METHODS
EP3801547A4 (en) CANCER TREATMENT METHODS
TWI848832B (zh) 用曲妥珠單抗安坦辛治療殘存乳癌之方法
SG11202103148QA (en) Methods of treating residual breast cancer with trastuzumab emtansine
EP3592357A4 (en) METHOD OF TREATMENT OF CANCER
EP3442555A4 (en) METHODS OF TREATING BREAST CANCER
EP4027989A4 (en) CANCER TREATMENT METHODS